Table 1.
List of the top 100 most cited articles in anaphylaxis(1991-2021)
| Rank | Article | Total Number of Citations | Average Citations per Year | Length of Time since Publication | IF |
|---|---|---|---|---|---|
| 1 | Sampson H A, Mendelson L, Rosen J P. Fatal and near-fatal anaphylactic reactions to food in children and adolescents[J]. New England Journal of Medicine, 1992, 327(6): 380–384 | 1243 | 41.43 | 30 | 91.253 |
| 2 | Bock S A, Muñoz-Furlong A, Sampson H A. Fatalities due to anaphylactic reactions to foods[J]. Journal of Allergy and Clinical Immunology, 2001, 107(1): 191–193 | 1173 | 55.86 | 21 | 10.793 |
| 3 | Chung C H, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1, 3-galactose[J]. New England journal of medicine, 2008, 358(11): 1109–1117 | 921 | 65.79 | 14 | 91.253 |
| 4 | Pumphrey R S H. Lessons for management of anaphylaxis from a study of fatal reactions[J]. Clinical and experimental allergy, 2000, 30(8): 1144–1150 | 693 | 31.50 | 22 | 5.018 |
| 5 | Brown S G A. Clinical features and severity grading of anaphylaxis[J]. Journal of Allergy and Clinical Immunology, 2004, 114(2): 371–376 | 548 | 30.44 | 18 | 10.793 |
| 6 | Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology[J]. Allergy, 2014, 69(8): 1026–1045 | 545 | 68.13 | 8 | 13.146 |
| 7 | Simons F E R, Ardusso L R F, Bilò M B, et al. World allergy organization guidelines for the assessment and management of anaphylaxis[J]. World Allergy Organization Journal, 2011, 4(2): 13–37 | 453 | 41.18 | 11 | 4.084 |
| 8 | Nelson H S, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract[J]. Journal of Allergy and Clinical Immunology, 1997, 99(6): 744–751 | 431 | 17.24 | 25 | 10.793 |
| 9 | Lieberman P, Nicklas R A, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update[J]. Journal of Allergy and Clinical immunology, 2010, 126(3): 477–480 | 401 | 33.42 | 12 | 10.793 |
| 10 | Commins S P, Satinover S M, Hosen J, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-α-1, 3-galactose[J]. Journal of Allergy and Clinical Immunology, 2009, 123(2): 426–433 | 388 | 29.85 | 13 | 10.793 |
| 11 | Sampson H A. Anaphylaxis and emergency treatment[J]. Pediatrics, 2003, 111(Supplement 3): 1601–1608 | 367 | 19.32 | 19 | 7.125 |
| 12* | Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology[J]. Allergy, 2007, 62(8): 857–871 | 365 | 24.33 | 15 | 13.146 |
| 13 | Mertes P M, Laxenaire M C, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000.[J]. Anesthesiology, 2003, 99(3):536 | 365 | 19.21 | 19 | 7.892 |
| 14 | Yocum M W, Butterfield J H, Klein J S, et al. Epidemiology of anaphylaxis in Olmsted County: a population-based study[J]. Journal of Allergy and Clinical Immunology, 1999, 104(2): 452–456 | 354 | 15.39 | 23 | 10.793 |
| 15 | Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis[J]. New England Journal of Medicine, 2008, 358(1): 28–35 | 346 | 24.71 | 14 | 91.253 |
| 16 | Turner P J, Gowland M H, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012[J]. Journal of Allergy and Clinical Immunology, 2015, 135(4): 956–963 | 337 | 48.14 | 7 | 10.793 |
| 17 | Simons F E R, Ardusso L R F, Bilò M B, et al. World Allergy Organization anaphylaxis guidelines: summary[J]. Journal of Allergy and Clinical Immunology, 2011, 127(3): 587–593 | 336 | 30.55 | 11 | 10.793 |
| 18 | Oettgen H C, Martin T R, Wynshaw-Boris A, et al. Active anaphylaxis in IgE-deficient mice[J]. Nature, 1994, 370(6488): 367–370 | 333 | 11.89 | 28 | 49.962 |
| 19 | Bernstein D I, Wanner M, Borish L, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001[J]. Journal of Allergy and Clinical Immunology, 2004, 113(6): 1129–1136 | 332 | 18.44 | 18 | 10.793 |
| 20 | Li X M, Serebrisky D, Lee S Y, et al. A murine model of peanut anaphylaxis: T-and B-cell responses to a major peanut allergen mimic human responses[J]. Journal of Allergy and Clinical Immunology, 2000, 106(1): 150–158 | 329 | 14.95 | 22 | 10.793 |
| 21* | Bochner B S, Lichtenstein L M. Anaphylaxis.[J]. New England Journal of Medicine, 1991, 324(25):1785–1790 | 329 | 10.61 | 31 | 91.253 |
| 22 | Liew W K, Williamson E, Tang M L K. Anaphylaxis fatalities and admissions in Australia[J]. Journal of Allergy and Clinical Immunology, 2009, 123(2): 434–442 | 322 | 24.77 | 13 | 10.793 |
| 23 | Brockow K, Jofer C, Behrendt H, et al. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients[J]. Allergy, 2008, 63(2): 226–232 | 320 | 22.86 | 14 | 13.146 |
| 24 | Schwartz, Lawrence B. Diagnostic value of tryptase in anaphylaxis and mastocytosis.[J]. Immunology and Allergy Clinics of North America, 2006, 26(3):451–463 | 315 | 19.69 | 16 | 3.479 |
| 25 | Sampson H A, Muñoz-Furlong A, Campbell R L, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium[J]. Journal of Allergy and Clinical Immunology, 2006, 117(2): 391–397 | 314 | 19.63 | 16 | 10.793 |
| 26 | Dombrowicz D, Flamand V, Brigman K K, et al. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene[J]. Cell, 1993, 75(5): 969–976 | 314 | 10.83 | 29 | 41.584 |
| 27 | Simons F E R, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines[J]. World Allergy Organization Journal, 2015, 8: 32 | 308 | 44.00 | 7 | 4.084 |
| 28* | Lieberman P, Camargo Jr C A, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American college of allergy, asthma and immunology epidemiology of anaphylaxis working group[J]. Annals of Allergy, Asthma and Immunology, 2006, 97(5): 596–602 | 306 | 19.13 | 16 | 6.347 |
| 29* | Kemp S F, Lockey R F. Anaphylaxis: a review of causes and mechanisms[J]. Journal of allergy and clinical immunology, 2002, 110(3): 341–348 | 301 | 15.05 | 20 | 10.793 |
| 30 | Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis[J]. Journal of Allergy and Clinical Immunology, 2010, 126(1): 83–91 | 300 | 25.00 | 12 | 10.793 |
| 31* | Finkelman F D. Anaphylaxis: lessons from mouse models[J]. Journal of Allergy and Clinical Immunology, 2007, 120(3): 506–515 | 300 | 20.00 | 15 | 10.793 |
| 32 | Ruëff F, Przybilla B, Biló M B, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase—a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity[J]. Journal of Allergy and Clinical Immunology, 2009, 124(5): 1047–1054 | 296 | 22.77 | 13 | 10.793 |
| 33 | Decker W W, Campbell R L, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project[J]. Journal of Allergy and Clinical Immunology, 2008, 122(6): 1161–1165 | 287 | 20.50 | 14 | 10.793 |
| 34 | Miyajima I, Dombrowicz D, Martin T R, et al. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG1-dependent passive anaphylaxis[J]. The Journal of clinical investigation, 1997, 99(5): 901–914 | 286 | 11.44 | 25 | 14.808 |
| 35 | Simons F E R. Anaphylaxis.[J]. Journal of Allergy and Clinical Immunology, 2010, 125(2):S161-S181 | 285 | 23.75 | 12 | 10.793 |
| 36 | Simons F E R, Roberts J R, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis[J]. Journal of Allergy and Clinical Immunology, 1998, 101(1): 33–37 | 273 | 11.38 | 24 | 10.793 |
| 37* | Neugut A I, Ghatak A T, Miller R L. Anaphylaxis in the United States: an investigation into its epidemiology[J]. Archives of internal medicine, 2001, 161(1): 15–21 | 272 | 12.95 | 21 | 17.333 |
| 38 | Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis[J]. Immunity, 2008, 28(4): 581–589 | 268 | 19.14 | 14 | 31.745 |
| 39 | Poulos L M, Waters A M, Correll P K, et al. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005[J]. Journal of Allergy and Clinical Immunology, 2007, 120(4): 878–884 | 261 | 17.40 | 15 | 10.793 |
| 40 | Grabenhenrich L B, Dölle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry[J]. Journal of Allergy and Clinical Immunology, 2016, 137(4): 1128–1137 | 259 | 43.17 | 6 | 10.793 |
| 41 | Brown A F T, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year[J]. Journal of Allergy and Clinical Immunology, 2001, 108(5): 861–866 | 254 | 12.10 | 21 | 10.793 |
| 42 | Lieberman P, Nicklas R A, Randolph C, et al. Anaphylaxis—a practice parameter update 2015[J]. Annals of Allergy, Asthma and Immunology, 2015, 115(5): 341–384 | 253 | 36.14 | 7 | 6.347 |
| 43 | Bonadonna P, Perbellini O, Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels[J]. Journal of allergy and clinical immunology, 2009, 123(3): 680–686 | 251 | 19.31 | 13 | 10.793 |
| 44* | Moneret‐Vautrin D A, Morisset M, Flabbee J, et al. Epidemiology of life‐threatening and lethal anaphylaxis: a review[J]. Allergy, 2005, 60(4): 443–451 | 249 | 14.65 | 17 | 13.146 |
| 45 | Rivas M N, Burton O T, Wise P, et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis[J]. Journal of Allergy and Clinical Immunology, 2013, 131(1): 201–212 | 245 | 27.22 | 9 | 10.793 |
| 46 | Laxenaire M C, Mertes P M, des Réactions Anaphylactoïdes G E. Anaphylaxis during anaesthesia. Results of a two‐year survey in France[J]. British Journal of Anaesthesia, 2001, 87(4): 549–558 | 237 | 11.29 | 21 | 9.166 |
| 47 | Laxenaire M C, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study[C]Annales Francaises D'anesthesie et de Reanimation. 1994, 13(3): 301–310 | 230 | 8.21 | 28 | 1.131 |
| 48* | Hepner D L, Castells M C. Anaphylaxis during the perioperative period[J]. Anesthesia and Analgesia, 2003, 97(5): 1381–1395 | 229 | 12.05 | 19 | 5.178 |
| 49 | Mertes P M, Alla F, Tréchot P, et al. Anaphylaxis during anesthesia in France: an 8-year national survey[J]. Journal of Allergy and Clinical Immunology, 2011, 128(2): 366–373 | 225 | 20.45 | 11 | 10.793 |
| 50 | Bohlke K, Davis R L, DeStefano F, et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization[J]. Journal of Allergy and Clinical Immunology, 2004, 113(3): 536–542 | 223 | 12.39 | 18 | 10.793 |
| 51 | Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical Practice[J]. Journal of Investigational Allergology and Clinical Immunology. 2011;21(6):442–453 | 220 | 20.00 | 11 | 7.033 |
| 52 | Rüggeberg J U, Gold M S, Bayas J M, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data[J]. Vaccine, 2007, 25(31): 5675–5684 | 220 | 14.67 | 15 | 3.641 |
| 53 | Schwartz L B, Bradford T R, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis[J]. Journal of clinical immunology, 1994, 14(3): 190–204 | 220 | 7.86 | 28 | 8.317 |
| 54 | Strait R T, Morris S C, Yang M, et al. Pathways of anaphylaxis in the mouse[J]. Journal of Allergy and Clinical Immunology, 2002, 109(4): 658–668 | 219 | 10.95 | 20 | 10.793 |
| 55* | Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction?[J]. Current opinion in allergy and clinical immunology, 2004, 4(4): 285–290 | 216 | 12.00 | 18 | 3.142 |
| 56 | Strait R T, Morris S C, Finkelman F D. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking[J]. The Journal of clinical investigation, 2006, 116(3): 833–841 | 213 | 13.31 | 16 | 14.808 |
| 57 | Kemp S F, Lockey R F, Wolf B L, et al. Anaphylaxis: a review of 266 cases[J]. Archives of internal medicine, 1995, 155(16): 1749–1754 | 213 | 7.89 | 27 | 17.333 |
| 58* | Panesar S S, Javad S, De Silva D, et al. The epidemiology of anaphylaxis in Europe: a systematic review[J]. Allergy, 2013, 68(11): 1353–1361 | 212 | 23.56 | 9 | 13.146 |
| 59 | Mangan N E, Fallon R E, Smith P, et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells[J]. The Journal of Immunology, 2004, 173(10): 6346–6356 | 212 | 11.78 | 18 | 5.422 |
| 60 | Laxenaire MC.Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Annales Francaises D'anesthesie et de Reanimation. 1999;18(7):796–809 | 212 | 9.22 | 23 | 1.131 |
| 61 | Kemp S F, Lockey R F, Simons F E R, et al. Epinephrine: the drug of choice for anaphylaxis–a statement of the World Allergy Organization[J]. World Allergy Organization Journal, 2008, 1: S18-S26 | 211 | 15.07 | 14 | 4.084 |
| 62 | Bohlke K, Davis R L, Marcy S M, et al. Risk of anaphylaxis after vaccination of children and adolescents[J]. Pediatrics, 2003, 112(4): 815–820 | 205 | 10.79 | 19 | 7.125 |
| 63 | Zabel B A, Nakae S, Zúñiga L, et al. Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis[J]. The Journal of experimental medicine, 2008, 205(10): 2207–2220 | 202 | 14.43 | 14 | 14.307 |
| 64 | Wood R A, Camargo Jr C A, Lieberman P, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States[J]. Journal of Allergy and Clinical Immunology, 2014, 133(2): 461–467 | 201 | 25.13 | 8 | 10.793 |
| 65* | Simons F E R, Frew A J, Ansotegui I J, et al. Risk assessment in anaphylaxis: current and future approaches[J]. Journal of allergy and clinical immunology, 2007, 120(1): S2-S24 | 201 | 13.40 | 15 | 10.793 |
| 66 | Jerschow E, Lin R Y, Scaperotti M M, et al. Fatal anaphylaxis in the United States, 1999–2010: temporal patterns and demographic associations[J]. Journal of allergy and clinical immunology, 2014, 134(6): 1318–1328 | 196 | 24.50 | 8 | 10.793 |
| 67 | Vennekens R, Olausson J, Meissner M, et al. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4[J]. Nature immunology, 2007, 8(3): 312–320 | 196 | 13.07 | 15 | 25.606 |
| 68 | Yunginger J W, Nelson D R, Squillace D L, et al. Laboratory investigation of deaths due to anaphylaxis[J]. Journal of Forensic Science, 1991, 36(3): 857–865 | 191 | 6.16 | 31 | 1.832 |
| 69 | Jönsson F, Mancardi D A, Kita Y, et al. Mouse and human neutrophils induce anaphylaxis[J]. The Journal of clinical investigation, 2011, 121(4): 1484–1496 | 190 | 17.27 | 11 | 14.808 |
| 70 | Braganza S C, Acworth J P, McKinnon D R L, et al. Paediatric emergency department anaphylaxis: different patterns from adults[J]. Archives of disease in childhood, 2006, 91(2): 159–163 | 187 | 11.69 | 16 | 3.801 |
| 71 | Webb L M, Lieberman P. Anaphylaxis: a review of 601 cases[J]. Annals of Allergy, Asthma and Immunology, 2006, 97(1): 39–43 | 186 | 11.63 | 16 | 6.347 |
| 72 | Steinke J W, Platts-Mills T A E, Commins S P. The alpha-gal story: lessons learned from connecting the dots[J]. Journal of Allergy and Clinical Immunology, 2015, 135(3): 589–596 | 183 | 26.14 | 7 | 10.793 |
| 73 | Metcalfe D D, Peavy R D, Gilfillan A M. Mechanisms of mast cell signaling in anaphylaxis[J]. Journal of Allergy and Clinical Immunology, 2009, 124(4): 639–646 | 183 | 14.08 | 13 | 10.793 |
| 74* | Simons F E R, Ardusso L R F, Bilo M B, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis[J]. Current opinion in allergy and clinical immunology, 2012, 12(4): 389–399 | 180 | 18.00 | 10 | 3.142 |
| 75 | Cox L, Platts-Mills T A E, Finegold I, et al. American academy of allergy, asthma & immunology/American college of allergy, asthma and immunology joint task force report on omalizumab-associated anaphylaxis[J]. Journal of allergy and clinical immunology, 2007, 120(6): 1373–1377 | 179 | 11.93 | 15 | 10.793 |
| 76 | Gold M S, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen)[J]. Journal of Allergy and Clinical Immunology, 2000, 106(1): 171–176 | 179 | 8.14 | 22 | 10.793 |
| 77* | Simons F E R, Ardusso L R F, Dimov V, et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base[J]. International archives of allergy and immunology, 2013, 162(3): 193–204 | 177 | 19.67 | 9 | 2.749 |
| 78 | Dohi M, Suko M, Sugiyama H, et al. Food-dependent, exercise-induced anaphylaxis: a study on 11 Japanese cases[J]. Journal of allergy and clinical immunology, 1991, 87(1): 34–40 | 177 | 5.71 | 31 | 10.793 |
| 79 | Palosuo K, Alenius H, Varjonen E, et al. A novel wheat gliadin as a cause of exercise-induced anaphylaxis[J]. Journal of Allergy and Clinical Immunology, 1999, 103(5): 912–917 | 176 | 7.65 | 23 | 10.793 |
| 80 | Ownby D R, Tomlanovich M, Sammons N, et al. Anaphylaxis associated with latex allergy during barium enema examinations[J]. AJR. American journal of roentgenology, 1991, 156(5): 903–908 | 174 | 5.61 | 31 | 3.959 |
| 81 | Yocum, M. W., & Khan, D. A. (1994). Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clinic Proceedings 69(1), 16–23 | 172 | 6.14 | 28 | 7.619 |
| 82 | Vultaggio A, Matucci A, Nencini F, et al. Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactions[J]. Allergy, 2010, 65(5): 657–661 | 170 | 14.17 | 12 | 13.146 |
| 83* | Lieberman P. Biphasic anaphylactic reactions[J]. Annals of allergy, asthma and immunology, 2005, 95(3): 217–226 | 170 | 10.00 | 17 | 6.347 |
| 84 | Pumphrey R S H, Roberts I S D. Postmortem findings after fatal anaphylactic reactions[J]. Journal of clinical pathology, 2000, 53(4): 273–276 | 170 | 7.73 | 22 | 3.411 |
| 85 | Srivastava K D, Kattan J D, Zou Z M, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy[J]. Journal of Allergy and Clinical Immunology, 2005, 115(1): 171–178 | 168 | 9.88 | 17 | 10.793 |
| 86* | Turner P J, Jerschow E, Umasunthar T, et al. Fatal anaphylaxis: mortality rate and risk factors[J]. The Journal of Allergy and Clinical Immunology: In Practice, 2017, 5(5): 1169–1178 | 167 | 33.40 | 5 | 8.861 |
| 87 | Mullins R J. Anaphylaxis: risk factors for recurrence[J]. Clinical and Experimental Allergy, 2003, 33(8): 1033–1040 | 167 | 8.79 | 19 | 5.018 |
| 88 | Helbling A, Hurni T, Mueller U R, et al. Incidence of anaphylaxis with circulatory symptoms: a study over a 3‐year period comprising 940 000 inhabitants of the Swiss Canton Bern[J]. Clinical and Experimental Allergy, 2004, 34(2): 285–290 | 166 | 9.22 | 18 | 5.018 |
| 89 | Novembre E, Cianferoni A, Bernardini R, et al. Anaphylaxis in children: clinical and allergologic features[J]. Pediatrics, 1998, 101(4): | 166 | 6.92 | 24 | 7.125 |
| 90 | Ross M P, Ferguson M, Street D, et al. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System[J]. Journal of Allergy and Clinical Immunology, 2008, 121(1): 166–171 | 165 | 11.79 | 14 | 10.793 |
| 91* | Kroigaard M, Garvey L H, Gillberg L, et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow‐up of anaphylaxis during anaesthesia[J]. Acta anaesthesiologica scandinavica, 2007, 51(6): 655–670 | 165 | 11.00 | 15 | 2.105 |
| 92 | Kelso J M, Jones R T, Yunginger J W. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin[J]. Journal of allergy and clinical immunology, 1993, 91(4): 867–872 | 165 | 5.69 | 29 | 10.793 |
| 93 | Olivera A, Mizugishi K, Tikhonova A, et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis[J]. Immunity, 2007, 26(3): 287–297 | 164 | 10.93 | 15 | 31.745 |
| 94 | Akin C, Scott L M, Kocabas C N, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis[J]. Blood, 2007, 110(7): 2331–2333 | 164 | 10.93 | 15 | 23.629 |
| 95 | Haeberli G, Brönnimann M, Hunziker T, et al. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy[J]. Clinical and Experimental Allergy, 2003, 33(9): 1216–1220 | 164 | 8.63 | 19 | 5.018 |
| 96 | Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children–a questionnaire‐based survey in Germany[J]. Allergy, 2005, 60(11): 1440–1445 | 163 | 9.59 | 17 | 13.146 |
| 97 | Shida K, Takahashi R, Iwadate E, et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model[J]. Clinical and Experimental Allergy, 2002, 32(4): 563–570 | 163 | 8.15 | 20 | 5.018 |
| 98* | De Silva I L, Mehr S S, Tey D, et al. Paediatric anaphylaxis: a 5 year retrospective review[J]. Allergy, 2008, 63(8): 1071–1076 | 158 | 11.29 | 14 | 13.146 |
| 99* | Simons F E R. Anaphylaxis: recent advances in assessment and treatment[J]. Journal of Allergy and Clinical Immunology, 2009, 124(4): 625–636 | 156 | 12.00 | 13 | 10.793 |
| 100 | Shadick N A, Liang M H, Partridge A J, et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study[J]. Journal of allergy and clinical immunology, 1999, 104(1): 123–127 | 156 | 6.78 | 23 | 10.793 |
*Review